Wealth Alliance’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Wealth Alliance’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000	Closed	-$218K	–	539
2023 Q1	$218K	Buy	+2,000	New	+$221K	0.04%	456
2022 Q4	–	Sell	-4,288	Closed	-$266K	–	516
2022 Q3	$266K	Sell	4,288 -585	-12%	-$40.9K	0.05%	352
2022 Q2	$389K	Buy	4,873 +354	+8%	+$33.5K	0.07%	259
2022 Q1	$475K	Sell	4,519 -110	-2%	-$10.7K	0.1%	227
2021 Q4	$499K	Sell	4,629 -83	-2%	-$9.05K	0.1%	224
2021 Q3	$516K	Sell	4,712 -886	-16%	-$92K	0.12%	194
2021 Q2	$524K	Buy	5,598 +841	+18%	+$77.4K	0.12%	188
2021 Q1	$438K	Sell	4,757 -2,699	-36%	-$228K	0.12%	197
2020 Q4	$545K	Sell	7,456 -14	-0.2%	-$1.04K	0.16%	159
2020 Q3	$580K	Buy	7,470 +200	+3%	+$13.8K	0.21%	124
2020 Q2	$404K	Buy	+7,270	New	+$311K	0.16%	166

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wealth Alliance's HZNP Position: Q2 2023 in Review

Wealth Alliance sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 2,000 shares — an estimated $218K sold.

Wealth Alliance first reported a position in HZNP in Q2 2020 and held it in 11 quarters. The position peaked at $580K in Q3 2020. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Wealth Alliance reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Wealth Alliance sold 2,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $218K.
Wealth Alliance first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 11 quarters.
Wealth Alliance's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $580K in Q3 2020.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Wealth Alliance's 13F filing for Q2 2023, filed 2 Aug 2023.